Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/07/2026 | Q4 2025 | N/A | $0.07 | N/A | N/A | $4.74 M |
| 09/30/2025 | Q3 2025 | N/A | $0.03 | N/A | N/A | $2.03 M |
| 06/30/2025 | Q2 2025 | N/A | $0.09 | N/A | N/A | $5.01 M |
| 03/31/2025 | Q1 2025 | N/A | $0.04 | N/A | N/A | $-3,129,086 |
| 12/31/2024 | Q4 2024 | N/A | -$0.03 | N/A | N/A | $2.53 M |
| 09/30/2024 | Q3 2024 | N/A | -$0.01 | N/A | N/A | $1.17 M |
| 06/30/2024 | Q2 2024 | N/A | $0.09 | N/A | N/A | $6.32 M |
| 03/31/2024 | Q1 2024 | N/A | $0.04 | N/A | N/A | $2.92 M |
| 12/31/2023 | Q4 2023 | N/A | $0.02 | N/A | N/A | $3.95 M |
| 09/30/2023 | Q3 2023 | N/A | $0.01 | N/A | N/A | $1.83 M |
| 06/30/2023 | Q2 2023 | N/A | $0.04 | N/A | N/A | $3.31 M |
| 03/31/2023 | Q1 2023 | N/A | $0.01 | N/A | N/A | $1.53 M |
| 12/31/2022 | Q4 2022 | N/A | $0.00 | N/A | N/A | $2.85 M |
| 09/30/2022 | Q3 2022 | N/A | $0.00 | N/A | N/A | $2.85 M |
| 06/30/2022 | Q2 2022 | N/A | $0.26 | N/A | N/A | $8.92 M |
| 03/31/2022 | Q1 2022 | N/A | $0.00 | N/A | N/A | $8.92 M |
The conference call for Anbio Biotechnology's latest earnings report can be listened to online.
The conference call transcript for Anbio Biotechnology's latest earnings report can be read online.
Anbio Biotechnology (:NNNN) has a recorded annual revenue of $8.65 M.
Anbio Biotechnology (:NNNN) has a recorded net income of $6.40 M.Anbio Biotechnology has generated $0.16 earnings per share over the last four quarters.
Anbio Biotechnology (:NNNN) has a price-to-earnings ratio of 18.56 and price/earnings-to-growth ratio is 0.19.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED